Send a donation View our products
Latest Posts

Fewer Mycophenolate Adverse Events in Scleroderma Lung Study

Mycophenolate mofetil can be substituted for cyclophosphamide for the immunosuppressive treatment of [...]

EGM Update

The Scleroderma Society held an EGM which commenced at 3:30pm today to vote on an amendment to the a [...]

Participate in new study comparing Ritixumab and Cyclophosphamide

Participate in a randomised, double blind controlled trial comparing Rituximab against intravenous C [...]

MHRA and BAD warning against Etin skin cream

The Medicines and Healthcare products Regulatory Agency (MHRA) and the British Association of Dermat [...]

Letter from SRUK’s CEO

Sue Farrington has recently been appointed as the CEO for Scleroderma and Raynaud’s UK (SRUK). [...]

Follow us on twitter